Literature DB >> 14649552

Possible mechanisms of osteopenia in Rett syndrome: bone histomorphometric studies.

Sarojini S Budden1, Michele E Gunness.   

Abstract

The etiology of frequently occurring osteoporosis in Rett syndrome is unknown. Five girls, ages 9.75, 11, 12, 13.5, and 14 years, with typical Rett syndrome requiring scoliosis surgery presented an opportunity to study bone remodeling by quantitative bone histomorphometry. Anterior iliac crest bone biopsies taken 1 to 2 days after double labeling of the bone surfaces with tetracycline were submitted for histomorphometry. Bone volume was reduced, and the surface parameters of formation (osteoid surface) were normal, whereas the parameters of resorption (osteoclast surface and number) were decreased. In four girls, the rate of bone formation was reduced but could not be measured in one girl owing to poor labeling. It is possible that the slow rate of bone formation impedes the development and accumulation of peak bone mass and contributes to the decreased bone volume in Rett syndrome. Perhaps MECP2 mutations in Rett syndrome not only influence brain development but also affect bone formation.

Entities:  

Mesh:

Year:  2003        PMID: 14649552     DOI: 10.1177/08830738030180100401

Source DB:  PubMed          Journal:  J Child Neurol        ISSN: 0883-0738            Impact factor:   1.987


  9 in total

Review 1.  Rett syndrome and MeCP2.

Authors:  Vichithra R B Liyanage; Mojgan Rastegar
Journal:  Neuromolecular Med       Date:  2014-03-11       Impact factor: 3.843

2.  Bone mass in Rett syndrome: association with clinical parameters and MECP2 mutations.

Authors:  Jay R Shapiro; Genila Bibat; Girish Hiremath; Mary E Blue; Shilpa Hundalani; Theodore Yablonski; Aditi Kantipuly; Charles Rohde; Michael Johnston; Sakkubai Naidu
Journal:  Pediatr Res       Date:  2010-11       Impact factor: 3.756

3.  Bone mineral content and bone mineral density are lower in older than in younger females with Rett syndrome.

Authors:  Kathleen J Motil; Kenneth J Ellis; Judy O Barrish; Erwin Caeg; Daniel G Glaze
Journal:  Pediatr Res       Date:  2008-10       Impact factor: 3.756

4.  In vivo genome-wide expression study on human circulating B cells suggests a novel ESR1 and MAPK3 network for postmenopausal osteoporosis.

Authors:  Peng Xiao; Yuan Chen; Hui Jiang; Yao-Zhong Liu; Feng Pan; Tie-Lin Yang; Zi-Hui Tang; Jennifer A Larsen; Joan M Lappe; Robert R Recker; Hong-Wen Deng
Journal:  J Bone Miner Res       Date:  2008-05       Impact factor: 6.741

5.  Teriparatide in the treatment of recurrent fractures in a Rett patient.

Authors:  Carla Caffarelli; Jussef Hayek; Ranuccio Nuti; Stefano Gonnelli
Journal:  Clin Cases Miner Bone Metab       Date:  2015-12-29

6.  Mecp2 deficiency decreases bone formation and reduces bone volume in a rodent model of Rett syndrome.

Authors:  R D O'Connor; M Zayzafoon; M C Farach-Carson; N C Schanen
Journal:  Bone       Date:  2009-05-03       Impact factor: 4.398

7.  Biomechanical properties of bone in a mouse model of Rett syndrome.

Authors:  Bushra Kamal; David Russell; Anthony Payne; Diogo Constante; K Elizabeth Tanner; Hanna Isaksson; Neashan Mathavan; Stuart R Cobb
Journal:  Bone       Date:  2014-10-24       Impact factor: 4.398

8.  Next generation phenotyping using narrative reports in a rare disease clinical data warehouse.

Authors:  Nicolas Garcelon; Antoine Neuraz; Rémi Salomon; Nadia Bahi-Buisson; Jeanne Amiel; Capucine Picard; Nizar Mahlaoui; Vincent Benoit; Anita Burgun; Bastien Rance
Journal:  Orphanet J Rare Dis       Date:  2018-05-31       Impact factor: 4.123

9.  Subclinical inflammatory status in Rett syndrome.

Authors:  Alessio Cortelazzo; Claudio De Felice; Roberto Guerranti; Cinzia Signorini; Silvia Leoncini; Alessandra Pecorelli; Gloria Zollo; Claudia Landi; Giuseppe Valacchi; Lucia Ciccoli; Luca Bini; Joussef Hayek
Journal:  Mediators Inflamm       Date:  2014-01-06       Impact factor: 4.711

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.